Author

Wei Tian

Observed name: Tian Wei

Institution: Shanxi Cardiovascular Hospital

Observed institutions: Tianjin University of Traditional Chinese Medicine, Shandong University, Second Hospital of Shandong University, Shanxi Cardiovascular Hospital

ORCID: 0000-0003-2398-5968

Observed ORCID: 0000-0003-2398-5968

OpenAlex ID: A5024556662

Recent progress in cancer cell membrane-based nanoparticles for biomedical applications

2023 · Qixiong Lin, Yueyou Peng, et al. · Beilstein Journal of Nanotechnology · 23

Integrating diagnosis and therapy in hepatocellular carcinoma: advances in nanotheranostics

2026 · Jiansong Shen, Yanyan Wen, et al. · Frontiers in Bioengineering and Biotechnology · 3

Anoikis-related long non-coding RNA signatures to predict prognosis and small molecular drug response in cervical cancer

2023 · Hao Liang, Lan Xiang, et al. · Frontiers in Pharmacology · 3

Identification of biomarkers based on ubiquitin-correlated genes for predicting immune profile and drug sensitivity in lung adenocarcinoma

2025 · Yue Li, Wei Tian, et al. · Frontiers in Pharmacology · 1

Radiofrequency enhances drug release from responsive nanoflowers for hepatocellular carcinoma therapy

2024 · Yanyan Wen, Ningning Song, et al. · Beilstein Journal of Nanotechnology · 1

Identification and validation of the necroptosis-related gene signature related to prognosis and tumor immune in hepatocellular carcinoma

2022 · Zhiping Xiang, Geofrey Mahiki Mranda, et al. · Medicine · 1

Works count: 6

Citation count: 32

H-index: 3

I10-index: 1